THE HETEROGENEITY OF GLIOBLASTOMA AND TREATMENTS

Abstract

Objective: This study aimed to describe glioblastoma, showing its epidemiology and histological characteristics. Also, show the types of diagnostic tests and treatments available. Methods: Surveys of scientific productions that addressed glioblastoma as a central theme, written in English or Portuguese, published from 2000 to 2020, were carried out. Conclusion: Glioblastoma is a primary brain tumor very prevalent in adults and often asymptomatic at first with nonspecific symptoms having a difficult and late diagnosis, with complex treatment. However, the prognosis of the disease is poor, with a survival of 4 to 6 months in patients who opt for no treatment and 14 months on average in patients with multimodal treatment.